oggbashan
Dying Truth seeker
- Joined
- Jul 3, 2002
- Posts
- 56,017
NICE fights the drug companies in the interests of the patients.
They push for clear demonstrations that expensive drugs have proven benefits that justify the cost. They set criteria for prescribing that have an evidential basis.
Patients sometimes think "It costs more, therefore it must be better". For basic over the counter painkillers that isn't necessarily true. A standard BP (British Pharmacopeia) painkiller such as soluble aspirin is usually as effective as a expensively advertised and brightly packaged branded aspirin.
As with all organisations, NICE sometimes gets it wrong. This time the internal dispute has gone public.
The point of NICE is to deliver the best, most cost-effective care to the whole population. Some of its decisions cause heartache because they deny, or make difficult, the prescribing of expensive drugs that have very limited value except for a particular stage of a specific condition when the public have been told (by the drug companies, of course) are the new wonder drug that will cure everything with no side-effects or contra-indications.
Prescribing drugs is not a win/win situation. Many powerful drugs have unpleasant side-effects and if prescribed for a condition that is not really appropriate, can cause more harm than good.
NICE isn't thought of as nice - but as a tool to manage the use of drugs in the UK it does its job reasonably. When it gets it wrong, the medical establishment are not reticent about challenging NICE through the media.
Og
They push for clear demonstrations that expensive drugs have proven benefits that justify the cost. They set criteria for prescribing that have an evidential basis.
Patients sometimes think "It costs more, therefore it must be better". For basic over the counter painkillers that isn't necessarily true. A standard BP (British Pharmacopeia) painkiller such as soluble aspirin is usually as effective as a expensively advertised and brightly packaged branded aspirin.
As with all organisations, NICE sometimes gets it wrong. This time the internal dispute has gone public.
The point of NICE is to deliver the best, most cost-effective care to the whole population. Some of its decisions cause heartache because they deny, or make difficult, the prescribing of expensive drugs that have very limited value except for a particular stage of a specific condition when the public have been told (by the drug companies, of course) are the new wonder drug that will cure everything with no side-effects or contra-indications.
Prescribing drugs is not a win/win situation. Many powerful drugs have unpleasant side-effects and if prescribed for a condition that is not really appropriate, can cause more harm than good.
NICE isn't thought of as nice - but as a tool to manage the use of drugs in the UK it does its job reasonably. When it gets it wrong, the medical establishment are not reticent about challenging NICE through the media.
Og
